Literature DB >> 23375205

Serum human chorionic gonadotropin levels on the day before oocyte retrieval do not correlate with oocyte maturity.

Gary Levy1, Micah J Hill, Christina Ramirez, Torrie Plowden, Justin Pilgrim, Robin S Howard, James H Segars, John Csokmay.   

Abstract

OBJECTIVE: To evaluate the correlation of preretrieval quantitative serum hCG level with oocyte maturity.
DESIGN: Retrospective cohort study.
SETTING: Military assisted reproductive technology (ART) program. PATIENT(S): Fresh autologous ART cycles. INTERVENTION(S): Serum hCG level the day before oocyte retrieval. MAIN OUTCOME MEASURE(S): Linear regression was used to correlate serum hCG levels and oocyte maturity rates. Normal oocyte maturity was defined as ≥75% and the Wilcoxon rank sum test was used to compare serum hCG levels in patients with normal and low oocyte maturity. Threshold analysis was performed to determine hCG levels that could predict oocyte maturity. RESULT(S): A total of 468 ART cycles were analyzed. Serum hCG level was not correlated with hCG dose; however, it was negatively correlated with body mass index (BMI). Serum hCG levels did not differ between patients with oocyte maturity of <75% and ≥75%. Serum hCG levels did not correlate with oocyte maturity rates. Receiver operator characteristic and less than efficiency curves failed to demonstrate thresholds at which hCG could predict oocyte maturity. CONCLUSION(S): Serum hCG levels were not correlated with oocyte maturity. Although a positive hCG was reassuring that mature oocytes would be retrieved for most patients, the specific value was not helpful.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375205      PMCID: PMC4152896          DOI: 10.1016/j.fertnstert.2012.12.053

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles.

Authors:  Iman Halvaei; Mohammad Ali Khalili; Mohammad Hossein Razi; Stefania A Nottola
Journal:  J Assist Reprod Genet       Date:  2012-05-30       Impact factor: 3.412

Review 2.  The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.

Authors:  M F G Verberg; M J C Eijkemans; N S Macklon; E M E W Heijnen; E B Baart; F P Hohmann; B C J M Fauser; F J Broekmans
Journal:  Hum Reprod Update       Date:  2009 Jan-Feb       Impact factor: 15.610

3.  Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial.

Authors:  E S Sills; C D Drews; M Perloe; C R Kaplan; M J Tucker
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

4.  Maturation arrest of human oocytes as a cause of infertility: case report.

Authors:  David Levran; Jacob Farhi; Hana Nahum; Marek Glezerman; Ariel Weissman
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

5.  Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?

Authors:  David E Reichman; Eleni Greenwood; Laura Meyer; Isaac Kligman; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2012-07-04       Impact factor: 7.329

6.  The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.

Authors:  G S Jones; J E Garcia; Z Rosenwaks
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

7.  Ovulation after intravenous and intramuscular human chorionic gonadotropin.

Authors:  R A Fischer; S T Nakajima; M Gibson; J R Brumsted
Journal:  Fertil Steril       Date:  1993-09       Impact factor: 7.329

8.  Microdose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization?

Authors:  Eric D Levens; Brian W Whitcomb; Jonathan D Kort; Donna Materia-Hoover; Frederick W Larsen
Journal:  Fertil Steril       Date:  2008-02-04       Impact factor: 7.329

9.  Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women.

Authors:  Carina C W Chan; Ernest H Y Ng; Maureen M Y Chan; Oi Shan Tang; Estella Y L Lau; William S B Yeung; Pak-Chung Ho
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

10.  Oocyte maturity in relation to woman's age in in vitro fertilization cycles stimulated by single regimen.

Authors:  Hee Jun Lee; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Shin Yong Moon
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

View more
  4 in total

1.  Low-Dose Urinary Human Chorionic Gonadotropin Is Effective for Oocyte Maturation in In Vitro Fertilization/ Intracytoplasmic Sperm Injection Cycles Independent of Body Mass Index.

Authors:  Luis R Hoyos; Sana Khan; Jing Dai; Manvinder Singh; Michael P Diamond; Elizabeth E Puscheck; Awoniyi O Awonuga
Journal:  Int J Fertil Steril       Date:  2016-11-11

2.  Impact of Serum Human Chorionic Gonadotropin and Luteinizing Hormone Receptor Expression to Oocyte Maturation Rate: A Study of Controlled Ovarian Stimulation.

Authors:  Hilwah Nora; Budi Wiweko; R Muharam; Grace Wangge; Andon Hestiantoro; Gita Pratama; Achmad Kemal Harzif; Sarah Chairani Zakirah
Journal:  J Hum Reprod Sci       Date:  2020-04-07

3.  Factors predicting clinical pregnancy rate of in vitro fertilization-embryo transfer (a STROBE-compliant article).

Authors:  Yi-Le Zhang; Fu-Zhen Wang; Kai Huang; Lin-Li Hu; Zhi-Qin Bu; Jing Sun; Ying-Chun Su; Yi-Hong Guo
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Serum hCG Levels following the Ovulatory Injection: Associations with Patient Weight and Implantation Time.

Authors:  Dorette J Noorhasan; Peter G McGovern; Michael Cho; Aimee Seungdamrong; Khaliq Ahmad; David H McCulloh
Journal:  Obstet Gynecol Int       Date:  2015-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.